Comparison · NCT01075178-849be72c
Palivizumab-treated Subjects (CASES) vs Non-palivizumab-treated Subjects (CONTROLS): Comparison Between CASES and CONTROLS of the Occurrence of Specific Clinical Outcomes of Death
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Palivizumab-treated Subjects (CASES) vs Non-palivizumab-treated Subjects (CONTROLS): Comparison Between CASES and CONTROLS of the Occurrence of Specific Clinical Outcomes of Death. Trial comparisons, record NCT01075178-849be72c. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01075178-849be72c
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.00892 | 0.0047 | 0.0169 | wilson | |
| Risk in group 2 | 0.00991 | 0.00539 | 0.0181 | wilson | |
| Risk difference, group 1 minus group 2 | -0.000991 | -0.0102 | 0.00815 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.9 | 0.367 | 2.21 | log | |
| Odds ratio, group 1 over group 2 | 0.899 | 0.364 | 2.22 | log | |
| Number needed to treat, for one fewer participant with the outcome on Palivizumab-treated Subjects (CASES) than on Non-palivizumab-treated Subjects (CONTROLS) | 1,009 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Palivizumab-treated Subjects (CASES) | HSCHD infants, \<2 yrs old at first dose of palivizumab | 9 | 1,009 | OG000 |
| Group 2 | Non-palivizumab-treated Subjects (CONTROLS) | HSCHD infants, \<2 yrs old that did not receive palivizumab | 10 | 1,009 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- PRIMARY
- Title
- Comparison Between CASES and CONTROLS of the Occurrence of Specific Clinical Outcomes of Death
- Description
- The number of subjects who died
- Time frame
- 8-month chart review period in CASES and CONTROLS
- Population
- The population analyzed included the full analysis set.
Source ClinicalTrials.gov
Trial
- Title
- Retrospective Palivizumab Study in Children With Hemodynamically Significant Congenital Heart Disease
- NCT number
- NCT01075178
- Phases
- Conditions
- Severe Respiratory Syncytial Virus Infection
- Interventions
- Lead sponsor
- Abbott
- Results first posted
- 2011-02-24
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01075178?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01075178-849be72c